organisation

EFCG’s strategy and work are managed by three Committees and one task force who report to and are directed by the EFCG Board

BOARD OF DIRECTORS

PRESIDENT
Dr. Steffen Denzinger
Director Business Development Actives & Formulation –
Merck Life Science KGaA

VICE-PRESIDENT
Dr. Gildas Barreyre
Energy and Public Affairs Director –
SEQENS

Ms. Ana Marti
General Counsel, IP & RA – Medichem S.A

Mr. Enrico Allievi
Director- Aschimfarma Federchimica

Mr. Gian Mario Baccalini
Curia Global

Dr. Christine Chartroux
Head of Sales & New Business development – WeylChem
Chair of the FAME Committee

Mr. David Demailly
API Commercial Director – Aspen Oss B.V.

Ms. Mila Jové
General Manager – Afaquim

Dr. Martin Jochen Klatt
Vice-President – BASF SE

 

Ms. Catherine Lequime
Managing Director – SICOS

Mr. Matt Moran
Director – BioPharmaChem Ireland

Dr. Gian Paolo Negrisoli
President and CEO – Flamma Group

Dr. Roberta Pizzocaro
President Olon Group

Dr. Jürgen Roos
Chief Scientific Officer – Siegfried Holding AG

Dr. Vincent Touraille
Head of Strategy – EuroAPI – Sanofi Chimie

MANAGER

Mrs. Maggie Saykali
Director, Specialty Chemicals – Cefic